\u30bb\u30ec\u30a4\u30c9<\/a>\u306e\u9020\u8840\u5e79\u7d30\u80de\u62e1\u5927\u80fd\u529b\u3092\u6d3b\u7528\u3057\u3001\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u3092\u62e1\u5927\u3059\u308b\u3053\u3068\u3067\u3001\u540c\u793e\u3092\u518d\u751f\u533b\u7642\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u4f4d\u7f6e\u3065\u3051\u3066\u3044\u307e\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"Celaid Therapeutics Inc. announced that it successfully completed the first close of its Series B financing. It raised JPY 1.055 billion, which is about USD 7.2 million. This funding came from venture capital firms and the Japan Agency for Medical Research and Development (AMED). Celaid has raised a total of JPY 2.52 billion (USD 17.14 million), including grants and subsidies. The funding shows increasing confidence in Celaid’s main program, CLD-001. This is an innovative therapy using ex vivo-expanded hematopoietic stem cells (HSCs) for severe pediatric non-malignant diseases. CLD-001 shows good promise in preclinical models. It has effective safety and notable advancements in cell manufacturing and CMC. The company is advancing […]<\/p>\n","protected":false},"author":7,"featured_media":22242,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,1,89,198,211,237,1838,206],"tags":[150,7467,8363,641,3874],"ppma_author":[572],"class_list":{"0":"post-22222","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-fintech","10":"category-health-tech","11":"category-investments","12":"category-japan","13":"category-news","14":"category-quick-reads","15":"category-regional","16":"tag-biotech","17":"tag-celaid-therapeutics","18":"tag-gmp-manufacturing","19":"tag-investment","20":"tag-series-b-financing"},"yoast_head":"\n
Celaid Raises \u00a51.05B to Advance Stem Cell Therapies<\/title>\n<meta name=\"description\" content=\"Celaid Therapeutics raised \u00a51.055B in Series B funding from VCs and AMED to advance stem cell therapy and platform expansion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-raises-\u00a51-05b-for-stem-cell-growth\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celaid Raises \u00a51.05B to Advance Stem Cell Therapies\" \/>\n<meta property=\"og:description\" content=\"Celaid Therapeutics raised \u00a51.055B in Series B funding from VCs and AMED to advance stem cell therapy and platform expansion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-raises-\u00a51-05b-for-stem-cell-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-08T13:08:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-08T13:08:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celaid Raises \u00a51.05B to Advance Stem Cell Therapies","description":"Celaid Therapeutics raised \u00a51.055B in Series B funding from VCs and AMED to advance stem cell therapy and platform expansion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-raises-\u00a51-05b-for-stem-cell-growth\/","og_locale":"ja_JP","og_type":"article","og_title":"Celaid Raises \u00a51.05B to Advance Stem Cell Therapies","og_description":"Celaid Therapeutics raised \u00a51.055B in Series B funding from VCs and AMED to advance stem cell therapy and platform expansion.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/celaid-therapeutics-raises-\u00a51-05b-for-stem-cell-growth\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-08T13:08:46+00:00","article_modified_time":"2025-10-08T13:08:47+00:00","og_image":[{"width":1201,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Celaid Therapeutics Raises \u00a51.05B for Stem Cell Growth","datePublished":"2025-10-08T13:08:46+00:00","dateModified":"2025-10-08T13:08:47+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/"},"wordCount":222,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp","keywords":["Biotech","Celaid Therapeutics","GMP manufacturing","Investment","Series B financing"],"articleSection":["APAC","Biotech","FinTech","Health Tech","Investments","Japan","News","Quick Reads","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/","name":"Celaid Raises \u00a51.05B to Advance Stem Cell Therapies","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp","datePublished":"2025-10-08T13:08:46+00:00","dateModified":"2025-10-08T13:08:47+00:00","description":"Celaid Therapeutics raised \u00a51.055B in Series B funding from VCs and AMED to advance stem cell therapy and platform expansion.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Celaid-Therapeutics-Raises-\u00a51.05B-for-Stem-Cell-Growth.webp","width":1201,"height":800,"caption":"Celaid-Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/celaid-therapeutics-raises-%c2%a51-05b-for-stem-cell-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Celaid Therapeutics Raises \u00a51.05B for Stem Cell Growth"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22222"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22222\/revisions"}],"predecessor-version":[{"id":22224,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22222\/revisions\/22224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22242"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22222"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}